Variant report
Variant | nsv514819 |
---|---|
Chromosome Location | chr16:80908579-80913603 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr16:80912981-80913285 | HepG2 | liver: | n/a | chr16:80913123-80913136 chr16:80913123-80913134 |
2 | CEBPB | chr16:80913064-80913219 | A549 | lung: | n/a | chr16:80913123-80913136 chr16:80913123-80913134 |
3 | CEBPB | chr16:80908811-80909220 | Hela-S3 | cervix: | n/a | n/a |
4 | E2F4 | chr16:80911280-80911354 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | EP300 | chr16:80908850-80909192 | Hela-S3 | cervix: | n/a | chr16:80909147-80909157 |
6 | MAFK | chr16:80911753-80911948 | HepG2 | liver: | n/a | n/a |
7 | MAZ | chr16:80912517-80912671 | HepG2 | liver: | n/a | n/a |
8 | POLR2A | chr16:80909927-80909973 | Gliobla | brain: | n/a | n/a |
9 | POLR2A | chr16:80912404-80912503 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr16:80909997-80910021 | A549 | lung: | n/a | n/a |
11 | POLR2A | chr16:80909680-80909781 | Gliobla | brain: | n/a | n/a |
12 | POLR2A | chr16:80909800-80909806 | Gliobla | brain: | n/a | n/a |
13 | POLR2A | chr16:80909811-80909836 | Gliobla | brain: | n/a | n/a |
14 | POLR2A | chr16:80911424-80911557 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr16:80909844-80909995 | A549 | lung: | n/a | n/a |
16 | TCF7L2 | chr16:80909087-80909152 | Hela-S3 | cervix: | n/a | n/a |
17 | USF2 | chr16:80909916-80909970 | HepG2 | liver: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:80905485..80908093-chr16:80908287..80911810,3 | K562 | blood: | |
2 | chr16:80909329..80911458-chr16:80945639..80947612,2 | MCF-7 | breast: | |
3 | chr16:80910057..80913120-chr16:80916062..80918233,3 | MCF-7 | breast: | |
4 | chr16:80897559..80901306-chr16:80907284..80910371,3 | MCF-7 | breast: | |
5 | chr16:80903251..80907289-chr16:80908287..80911628,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000260896 | TF binding region |
ENSG00000260896 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35301463 | chr16:80908579-80908580 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs78886998 | chr16:80908581-80908582 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs552322599 | chr16:80908616-80908617 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs570527018 | chr16:80908626-80908627 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs376493423 | chr16:80908637-80908638 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs186495253 | chr16:80908642-80908643 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs553053842 | chr16:80908646-80908647 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs563613538 | chr16:80908651-80908652 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs532859270 | chr16:80908665-80908666 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs377601352 | chr16:80908684-80908685 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs574652276 | chr16:80908691-80908692 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs552631370 | chr16:80908751-80908752 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs1423852 | chr16:80908761-80908762 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs528727120 | chr16:80908773-80908774 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs548693384 | chr16:80908830-80908831 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs557633592 | chr16:80908855-80908856 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs190918639 | chr16:80908865-80908866 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs74028811 | chr16:80908903-80908904 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs557755084 | chr16:80908912-80908913 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs11862284 | chr16:80908913-80908914 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs535678392 | chr16:80908917-80908918 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs561805092 | chr16:80908961-80908962 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs139186842 | chr16:80908979-80908980 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs2549757 | chr16:80909019-80909020 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs562785261 | chr16:80909021-80909022 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs144448462 | chr16:80909039-80909040 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs551676015 | chr16:80909048-80909049 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs182188467 | chr16:80909060-80909061 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs528476378 | chr16:80909093-80909094 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs186678008 | chr16:80909131-80909132 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs568264021 | chr16:80909137-80909138 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs146123379 | chr16:80909189-80909190 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs570620735 | chr16:80909195-80909196 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs140107692 | chr16:80909200-80909201 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs142466894 | chr16:80909205-80909206 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs539694851 | chr16:80909221-80909222 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs191090318 | chr16:80909237-80909238 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs375600700 | chr16:80909239-80909240 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs572864790 | chr16:80909240-80909241 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs541845790 | chr16:80909246-80909247 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs540276597 | chr16:80909266-80909267 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs35941474 | chr16:80909306-80909307 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs74028812 | chr16:80909314-80909315 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs573687566 | chr16:80909320-80909321 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs12446655 | chr16:80909378-80909379 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs112862579 | chr16:80909434-80909435 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs199941178 | chr16:80909462-80909463 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs67444421 | chr16:80909463-80909464 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs398119547 | chr16:80909465-80909466 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs373713690 | chr16:80909500-80909501 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Obesity | 20622171 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:80908400-80909600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr16:80908600-80909400 | Enhancers | Hela-S3 | cervix |
3 | chr16:80908800-80909800 | Enhancers | Fetal Lung | lung |
4 | chr16:80908800-80910200 | Enhancers | Pancreas | Pancrea |
5 | chr16:80909400-80909600 | Enhancers | Liver | Liver |
6 | chr16:80909400-80910800 | Weak transcription | Hela-S3 | cervix |
7 | chr16:80909600-80910000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr16:80909600-80910000 | Active TSS | Adipose Nuclei | Adipose |
9 | chr16:80909600-80910000 | Flanking Active TSS | Liver | Liver |
10 | chr16:80909600-80910000 | Active TSS | Duodenum Mucosa | Duodenum |
11 | chr16:80909600-80910000 | Flanking Active TSS | Fetal Adrenal Gland | Adrenal Gland |
12 | chr16:80909600-80910000 | Enhancers | Right Ventricle | heart |
13 | chr16:80909600-80910000 | Bivalent/Poised TSS | NHDF-Ad | bronchial |
14 | chr16:80909600-80910200 | Enhancers | Gastric | stomach |
15 | chr16:80909800-80910000 | Flanking Bivalent TSS/Enh | Left Ventricle | heart |
16 | chr16:80909800-80910000 | Enhancers | Sigmoid Colon | Sigmoid Colon |
17 | chr16:80909800-80910000 | Bivalent Enhancer | Small Intestine | intestine |
18 | chr16:80909800-80910200 | Enhancers | Lung | lung |
19 | chr16:80909800-80910200 | Enhancers | Right Atrium | heart |
20 | chr16:80910000-80910200 | Bivalent Enhancer | Aorta | Aorta |
21 | chr16:80910000-80910200 | Bivalent Enhancer | Left Ventricle | heart |
22 | chr16:80910000-80910400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
23 | chr16:80910200-80916800 | Weak transcription | Gastric | stomach |
24 | chr16:80910800-80911000 | Enhancers | Hela-S3 | cervix |